Header Logo

Connection

Omid Khorram to Leiomyoma

This is a "connection" page, showing publications Omid Khorram has written about Leiomyoma.
Connection Strength

19.848
  1. In vivo inhibition of TDO2 in fibroids results in widespread alteration in the tumor transcriptome. Clin Sci (Lond). 2026 Jun 10; 140(6):1099-1117.
    View in: PubMed
    Score: 0.897
  2. Transcriptomic and functional analysis of fibroid extracellular vesicles. Clin Sci (Lond). 2026 May 20; 140(5):805-824.
    View in: PubMed
    Score: 0.893
  3. The Roles of Non-Coding RNAs in the Pathogenesis of Uterine Fibroids. Cells. 2025 Aug 20; 14(16).
    View in: PubMed
    Score: 0.848
  4. Comparative Analysis of Differentially Expressed Long Non-Coding RNA in Pre- and Postmenopausal Fibroids. Int J Mol Sci. 2025 Jul 16; 26(14).
    View in: PubMed
    Score: 0.843
  5. Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas. Int J Mol Sci. 2025 Feb 16; 26(4).
    View in: PubMed
    Score: 0.819
  6. The in?vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression. FASEB J. 2024 Nov 15; 38(21):e70140.
    View in: PubMed
    Score: 0.805
  7. The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis. Int J Mol Sci. 2024 Oct 27; 25(21).
    View in: PubMed
    Score: 0.802
  8. The immune landscape of uterine fibroids as determined by mass cytometry. F S Sci. 2024 Aug; 5(3):272-282.
    View in: PubMed
    Score: 0.783
  9. In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study. Cells. 2024 Jun 24; 13(13).
    View in: PubMed
    Score: 0.783
  10. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clin Sci (Lond). 2024 Jun 19; 138(12):699-709.
    View in: PubMed
    Score: 0.782
  11. The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium. Int J Mol Sci. 2024 Jan 21; 25(2).
    View in: PubMed
    Score: 0.760
  12. Therapeutic effects of in?vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study. Fertil Steril. 2024 Apr; 121(4):669-678.
    View in: PubMed
    Score: 0.754
  13. The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids. Int J Mol Sci. 2023 Aug 30; 24(17).
    View in: PubMed
    Score: 0.740
  14. Therapeutic Effects of Long-Term Administration of Tranilast in an Animal Model for the Treatment of Fibroids. Int J Mol Sci. 2023 Jun 21; 24(13).
    View in: PubMed
    Score: 0.730
  15. Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas. Int J Mol Sci. 2023 Feb 13; 24(4).
    View in: PubMed
    Score: 0.713
  16. Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas. Reprod Sci. 2022 10; 29(10):2960-2976.
    View in: PubMed
    Score: 0.678
  17. Further characterization of tryptophan metabolism and its dysregulation in fibroids. F S Sci. 2022 11; 3(4):392-400.
    View in: PubMed
    Score: 0.675
  18. Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family. Endocrinology. 2021 11 01; 162(11).
    View in: PubMed
    Score: 0.652
  19. Fibroid stiffness: a cellular modulator of progesterone receptor signaling. Fertil Steril. 2021 07; 116(1):91.
    View in: PubMed
    Score: 0.637
  20. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021 10; 116(4):1160-1171.
    View in: PubMed
    Score: 0.634
  21. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Fertil Steril. 2021 01; 115(1):238-247.
    View in: PubMed
    Score: 0.606
  22. Tranilast induces MiR-200c expression through blockade of RelA/p65 activity in leiomyoma smooth muscle cells. Fertil Steril. 2020 06; 113(6):1308-1318.
    View in: PubMed
    Score: 0.582
  23. Cross-talk between miR-29c and transforming growth factor-ß3 is mediated by an epigenetic mechanism in leiomyoma. Fertil Steril. 2019 12; 112(6):1180-1189.
    View in: PubMed
    Score: 0.571
  24. Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma. Fertil Steril. 2018 05; 109(5):919-929.
    View in: PubMed
    Score: 0.511
  25. Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma. Reprod Sci. 2019 02; 26(2):250-258.
    View in: PubMed
    Score: 0.509
  26. Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing. Reprod Sci. 2018 02; 25(2):246-255.
    View in: PubMed
    Score: 0.480
  27. Tranilast Inhibits Genes Functionally Involved in Cell Proliferation, Fibrosis, and Epigenetic Regulation and Epigenetically Induces miR-29c Expression in Leiomyoma Cells. Reprod Sci. 2017 09; 24(9):1253-1263.
    View in: PubMed
    Score: 0.465
  28. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma. Fertil Steril. 2016 Jan; 105(1):236-45.e1.
    View in: PubMed
    Score: 0.428
  29. miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. PLoS One. 2014; 9(4):e95370.
    View in: PubMed
    Score: 0.387
  30. Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions. Mol Hum Reprod. 2002 Jan; 8(1):75-80.
    View in: PubMed
    Score: 0.041
  31. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril. 2001 Jan; 75(1):174-9.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.